Janssen reaches partial agreement over criminal investigation
August 10, 2011Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
TranslateMedia launches its new global translation platform, STREAM
August 10, 2011Global translation agency TranslateMedia is releasing a new version of its award-winning translation platform. The latest version – TranslateMedia STREAM …
Nanoparticles to target Alzheimer’s disease
August 10, 2011Research and Development Alzheimer's, nanoparticles
Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …
New MS drug shows promise for Abbott
August 10, 2011Research and Development, Sales and Marketing Abbott, Avonex, Biogen, MS, gilenya
Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …
NICE wants more RoActemra data for juvenile idiopathic arthritis
August 9, 2011Medical Communications NICE, RoActemra, Roche
NICE has requested more evidence from Roche for RoActemra in childhood arthritis. RoActemra (tocilizumab) is being assessed for the treatment …
Shared API inspections project declared a success
August 9, 2011Manufacturing and Production API, EMA, FDA, TGA, pharma manufacturing news, regulatory inspections
A two-year facility inspection programme carried out by regulators in the USA, Europe and Australia has been deemed a success …
Taskforce to tackle £300m in wasted medicines
August 9, 2011Sales and Marketing Lord Howe, NHS, medinces management
A task force has been set up to tackle medicine wastage in the NHS – a problem which, the government …
Pfizer teams up with University of California for drug discovery
August 9, 2011Research and Development, Sales and Marketing Pfizer, academic research
Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …
Investment firm adds Roche facility to growing portfolio
August 9, 2011Manufacturing and Production Colarado, International Chemical Investors, Roche, pharma manufacturing news
International Chemical Investors Group has snapped up another manufacturing facility, this time agreeing to buy a plant owned by Roche …
SkyePharma leases manufacturing business to CMO
August 9, 2011Manufacturing and Production Aenova, Skyepharma, pharma manufacturing news
German contract manufacturer Aenova is to lease a manufacturing unit near Lyon, France, from UK drugmaker SkyePharma. Aenova has taken …
Lonza profits slide as exchange rates bite
August 9, 2011Manufacturing and Production CMO, Lonza
A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …
Pradaxa approved for stroke prevention in Europe
August 9, 2011Sales and Marketing Pradaxa, atrial fibrillation, direct thrombin inhibitor
Boehringer Ingelheim’s Pradaxa has become the first drug in 50 years to be approved in Europe for stroke prevention in …
Gilead buys manufacturing plant from Genentech
August 9, 2011Manufacturing and Production Genentech, Gilead, biologics
Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …
Takeda and Amylin stop obesity trial
August 8, 2011Research and Development, Sales and Marketing Amylin, Takeda
Takeda and Amylin have decided to halt further studies of its combination treatment for obesity, due to ‘evolving dynamics’ within …
Biotica becomes new victim of Pfizer’s R&D downsizing
August 8, 2011Research and Development, Sales and Marketing
Pfizer has pulled out of a $195 million deal with UK firm Biotica, as it continues to downsize its global …
Meet Wainwright Associates at the TOPRA Symposium and CPhl worldwide
August 7, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
Wainwright Associates is an independent company offering consultancy services to the pharmaceutical, medical device and healthcare industry in Product Development, …
Dissent over patient involvement reforms
August 5, 2011Medical Communications HealthWatch, NHS, patient involvement
The first 75 ‘pathfinders’ have been named in Local HealthWatch, the patient representative organisations due to replace the current local …
Gilenya rejected by NICE
August 5, 2011Medical Communications, Sales and Marketing MS, NICE, Novartis, gilenya
NICE has not recommended Novartis’ multiple sclerosis drug Gilenya because of its cost and ‘uncertainties over its clinical effectiveness’. Gilenya …
First personalised asthma drug shows promise
August 4, 2011Roche, asthma, personalised medicine
Roche’s personalised asthma drug lebrikizumab has met its primary end point in a phase II trial. Lebrikizumab increased the level …
NHS must personalise services for long-term conditions
August 3, 2011Sales and Marketing NHS, long term conditions
The government is highlighting a scheme in West Yorkshire as providing a way forward for reducing the cost burden on …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
